The retrospective assessment of surgical resection in the management of small cell carcinoma of the lung.
Role of surgical resection for small cell lung carcinoma (SCLC) was retrospectively assessed in 16 patients with pTNM-stage I and 13 with pTNM-stages II and IIIA. The 3-year and 5-year survival rates in patients with stage I were 61% and 45%, respectively, and the median survival time (MST) was 23.5 months. On the other hand, the 3-year survival rate for the 13 surgical patients with stages II and IIIA was 28% (MST=19 m), which showed no statistical difference between that of 21% (MST=10 m) for the 16 non-surgical patients with clinical stages II acid IIIA. These results suggest that resection is desirable for patients with stage I, but is of no benefit for patients with stages II and IIIA.